Long-term outcomes of an esophagus-preserving chemoradiotherapy strategy for patients with endoscopically unresectable stage I thoracic esophageal squamous cell carcinoma-Reference-Cited by-同舟云学术

Long-term outcomes of an esophagus-preserving chemoradiotherapy strategy for patients with endoscopically unresectable stage I thoracic esophageal squamous cell carcinoma

Published:2021-09 Issue: Volume:30 Page:88-94
ISSN:2405-6308
Container-title:Clinical and Translational Radiation Oncology
language:en
Short-container-title:Clinical and Translational Radiation Oncology

Author:

Suwa Tatsuya,Ishida Yuichi,Negoro Yoshiharu,Kusumi Fusako,Kadokawa Yoshio,Aizawa Rihito,Nakajima Toshifumi,Okamoto Yoshiaki,Okuno Yoshishige,Yamada Kazunari,Ogura Masakazu,Murakami Masao,Mizowaki Takashi

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology

Reference34 articles.

1. Early detection and therapeutics;Januszewicz;Mol Oncol,2019

2. Successful screening for early esophageal cancer in alcoholics using endoscopy and mucosa iodine staining;Yokoyama;Cancer,1995

3. Lymph node metastases in esophageal carcinoma: an endoscopist's view;Cho;Clin Endosc,2014

4. INT 0123 (Radiation Therapy Oncology Group 94–05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy;Minsky;J Clin Oncol,2002

5. Igaki H, Kato H, Tachimori Y, Daiko H, Fukaya M, Yajima S, et al. Clinicopathologic characteristics and survival of patients with clinical Stage I squamous cell carcinomas of the thoracic esophagus treated with three-field lymph node dissection. Eur J Cardio-thoracic Surgery. 2001;20:1089-94.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between Submucosal Fibrosis and Endoscopic Submucosal Dissection of Recurrent Esophageal Squamous Cell Cancers after Chemoradiotherapy;Cancers;2022-09-26

2. Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery in patients with locally advanced esophageal squamous cell carcinoma who achieved clinical complete response when induction chemoradiation finished: A phase II random;Radiotherapy and Oncology;2022-09